AMNEAL PHARMACEUTICALS, INC. Impairment of Intangible Assets (Excluding Goodwill)
AMNEAL PHARMACEUTICALS, INC. (AMRX) reported Impairment of Intangible Assets (Excluding Goodwill) of $0 for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill · last filed 2026-08-06
- AMNEAL PHARMACEUTICALS, INC. impairment of intangible assets (excluding goodwill) for the quarter ending 2026-06-30 was $0.00.
- AMNEAL PHARMACEUTICALS, INC. impairment of intangible assets (excluding goodwill) for the quarter ending 2026-03-31 was $0.00.
- AMNEAL PHARMACEUTICALS, INC. impairment of intangible assets (excluding goodwill) for the quarter ending 2025-12-31 was $0.00.
- AMNEAL PHARMACEUTICALS, INC. impairment of intangible assets (excluding goodwill) for the quarter ending 2025-09-30 was $22.80M.
- AMNEAL PHARMACEUTICALS, INC. impairment of intangible assets (excluding goodwill) for fiscal 2025 was $22.78M, a 2376.52% increase from fiscal 2024.
- AMNEAL PHARMACEUTICALS, INC. impairment of intangible assets (excluding goodwill) for fiscal 2024 was $920.00K, a 98.63% decline from fiscal 2023.
- AMNEAL PHARMACEUTICALS, INC. impairment of intangible assets (excluding goodwill) for fiscal 2023 was $66.93M, a 177.95% increase from fiscal 2022.
- AMNEAL PHARMACEUTICALS, INC. impairment of intangible assets (excluding goodwill) for fiscal 2022 was $24.08M, a 2.90% increase from fiscal 2021.
| Period end | Impairment of Intangible Assets (Excluding Goodwill) 3 month | Impairment of Intangible Assets (Excluding Goodwill) 6 month | Impairment of Intangible Assets (Excluding Goodwill) 9 month | Impairment of Intangible Assets (Excluding Goodwill) 12 month | Impairment of Intangible Assets (Excluding Goodwill) 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-06 | $0.00 10-Q · filed 2026-08-06 | $0.00 derived: sum of 3 quarters · filed 2026-08-06 | $22.80M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-07 | $0.00 derived: sum of 2 quarters · filed 2026-05-07 | $22.80M derived: sum of 3 quarters · filed 2026-05-07 | $22.80M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $22.80M derived: sum of 2 quarters · filed 2026-02-27 | $22.80M derived: sum of 3 quarters · filed 2026-08-06 | $22.78M 10-K · filed 2026-02-27 | |
| 2025-09-30 | $22.80M 10-Q · filed 2025-11-06 | $22.80M derived: sum of 2 quarters · filed 2026-08-06 | $22.78M 10-Q · filed 2025-11-06 | $22.80M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-06-30 | $0.00 10-Q · filed 2026-08-06 | $0.00 10-Q · filed 2026-08-06 | $0.00 derived: sum of 3 quarters · filed 2026-08-06 | $0.00 derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-07 | $0.00 derived: sum of 2 quarters · filed 2026-05-07 | $0.00 derived: sum of 3 quarters · filed 2026-05-07 | $0.00 derived: sum of 4 quarters · filed 2026-05-07 | |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $0.00 derived: sum of 2 quarters · filed 2026-02-27 | $0.00 derived: sum of 3 quarters · filed 2026-02-27 | $920.00K 10-K · filed 2026-02-27 | |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $0.00 derived: sum of 2 quarters · filed 2025-11-06 | $920.00K 10-Q · filed 2025-11-06 | $65.82M derived: sum of 4 quarters · filed 2026-02-27 | |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $920.00K 10-Q · filed 2025-08-07 | $65.82M derived: sum of 3 quarters · filed 2026-02-27 | $66.57M derived: sum of 4 quarters · filed 2026-02-27 | |
| 2024-03-31 | $920.00K 10-Q · filed 2025-05-07 | $65.82M derived: sum of 2 quarters · filed 2026-02-27 | $66.57M derived: sum of 3 quarters · filed 2026-02-27 | $67.85M derived: sum of 4 quarters · filed 2026-02-27 | |
| 2023-12-31 | $64.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $65.65M derived: sum of 2 quarters · filed 2026-02-27 | $66.93M derived: sum of 3 quarters · filed 2026-02-27 | $66.93M 10-K · filed 2026-02-27 | |
| 2023-09-30 | $753.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $2.04M derived: sum of 2 quarters · filed 2024-11-12 | $2.04M 10-Q · filed 2024-11-12 | $20.33M derived: sum of 4 quarters · filed 2025-02-28 | |
| 2023-06-30 | $1.28M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $1.28M 10-Q · filed 2024-08-09 | $19.58M derived: sum of 3 quarters · filed 2025-02-28 | $20.25M derived: sum of 4 quarters · filed 2025-02-28 | |
| 2023-03-31 | $0.00 10-Q · filed 2024-05-08 | $18.30M derived: sum of 2 quarters · filed 2025-02-28 | $18.97M derived: sum of 3 quarters · filed 2025-02-28 | ||
| 2022-12-31 | $18.30M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $18.97M derived: sum of 2 quarters · filed 2025-02-28 | $24.08M 10-K · filed 2025-02-28 | ||
| 2022-09-30 | $674.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $5.79M 10-Q · filed 2023-11-09 | |||
| 2022-06-30 | $5.11M 10-Q · filed 2023-08-08 | ||||
| 2021-12-31 | $22.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | $22.69M derived: sum of 2 quarters · filed 2024-03-14 | $23.40M derived: sum of 3 quarters · filed 2024-03-14 | $23.40M 10-K · filed 2024-03-14 | |
| 2021-09-30 | $688.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | $1.40M derived: sum of 2 quarters · filed 2022-11-07 | $1.40M 10-Q · filed 2022-11-07 | $3.12M derived: sum of 4 quarters · filed 2023-03-03 | |
| 2021-06-30 | $710.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $710.00K 10-Q · filed 2022-08-08 | $2.43M derived: sum of 3 quarters · filed 2023-03-03 | $34.79M derived: sum of 4 quarters · filed 2023-03-03 | |
| 2021-03-31 | $0.00 10-Q · filed 2021-05-07 | $1.72M derived: sum of 2 quarters · filed 2023-03-03 | $34.08M derived: sum of 3 quarters · filed 2023-03-03 | $34.84M derived: sum of 4 quarters · filed 2023-03-03 | |
| 2020-12-31 | $1.72M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-03 | $34.08M derived: sum of 2 quarters · filed 2023-03-03 | $34.84M derived: sum of 3 quarters · filed 2023-03-03 | $37.26M 10-K · filed 2023-03-03 | |
| 2020-09-30 | $32.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $33.12M derived: sum of 2 quarters · filed 2021-11-08 | $35.54M 10-Q · filed 2021-11-08 | $49.71M derived: sum of 4 quarters · filed 2022-03-01 | |
| 2020-06-30 | $759.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $3.17M 10-Q · filed 2021-08-09 | $17.35M derived: sum of 3 quarters · filed 2022-03-01 | $96.86M derived: sum of 4 quarters · filed 2022-03-01 | |
| 2020-03-31 | $2.42M 10-Q · filed 2021-05-07 | $16.59M derived: sum of 2 quarters · filed 2022-03-01 | $96.10M derived: sum of 3 quarters · filed 2022-03-01 | $99.11M derived: sum of 4 quarters · filed 2022-03-01 | |
| 2019-12-31 | $14.17M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $93.69M derived: sum of 2 quarters · filed 2022-03-01 | $96.70M derived: sum of 3 quarters · filed 2022-03-01 | $172.78M 10-K · filed 2022-03-01 | |
| 2019-09-30 | $79.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $82.53M derived: sum of 2 quarters · filed 2020-11-06 | $158.61M 10-Q · filed 2020-11-06 | $197.21M derived: sum of 4 quarters · filed 2021-03-01 | |
| 2019-06-30 | $3.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $79.10M 10-Q · filed 2020-08-06 | $117.70M derived: sum of 3 quarters · filed 2021-03-01 | $126.17M derived: sum of 4 quarters · filed 2021-03-01 | |
| 2019-03-31 | $76.08M 10-Q · filed 2020-05-11 | $114.68M derived: sum of 2 quarters · filed 2021-03-01 | $123.16M derived: sum of 3 quarters · filed 2021-03-01 | $123.16M derived: sum of 4 quarters · filed 2021-03-01 | |
| 2018-12-31 | $38.60M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $47.07M derived: sum of 2 quarters · filed 2021-03-01 | $47.07M derived: sum of 3 quarters · filed 2021-03-01 | $47.07M 10-K · filed 2021-03-01 | $47.93M 10-K · filed 2019-03-01 |
| 2018-09-30 | $8.47M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $8.47M derived: sum of 2 quarters · filed 2019-11-07 | $8.47M 10-Q · filed 2019-11-07 | $8.47M derived: sum of 4 quarters · filed 2020-03-02 | |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-05 | $0.00 10-Q · filed 2019-08-05 | $0.00 derived: sum of 3 quarters · filed 2020-03-02 | ||
| 2018-03-31 | $0.00 10-Q · filed 2019-05-09 | $0.00 derived: sum of 2 quarters · filed 2020-03-02 | |||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $0.00 10-K · filed 2020-03-02 | |||
| 2017-09-30 | $0.00 10-Q · filed 2018-11-07 | ||||
| 2016-12-31 | $0.00 10-K · filed 2019-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |